2021
DOI: 10.1002/ajmg.a.62174
|View full text |Cite|
|
Sign up to set email alerts
|

Parental mosaicism in de novo neurodevelopmental diseases

Abstract: Neurodevelopmental diseases are increasingly recognized to be caused by “de novo” variants with the expanding use of next‐generation sequencing. The apparent de novo variants may actually be low‐level hereditary parental mosaic variants, which could increase the recurrence risk of disease by >50% and is thought to be an underappreciated cause of neurodevelopmental diseases. Our study aimed to investigate the frequency of parental mosaicism in “de novo” neurodevelopmental diseases. A total of 237 patients (and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 30 publications
2
7
0
Order By: Relevance
“…Furthermore, we quantity the contribution of parental mosaicism to presumed de novo non‐mosaic disease (2.86% and 2.34% in the UDN and VEHR cohorts) in a non‐disease specific manner. Our findings fall in the range predicted in previous disease‐specific studies which estimated the disease‐specific prevalence of 0.5% and 8.3% (Acuna‐Hidalgo et al, 2015; Campbell, Yuan, et al, 2014; Domogala et al, 2021; Shu et al, 2021; Wright et al, 2019). We think this is likely to be an underestimation because low parental allele reads, or analysis pipelines prevent detection of low variant allele copy numbers and the lack of parental phenotypic exams conducted in routine practice.…”
Section: Discussionsupporting
confidence: 75%
See 1 more Smart Citation
“…Furthermore, we quantity the contribution of parental mosaicism to presumed de novo non‐mosaic disease (2.86% and 2.34% in the UDN and VEHR cohorts) in a non‐disease specific manner. Our findings fall in the range predicted in previous disease‐specific studies which estimated the disease‐specific prevalence of 0.5% and 8.3% (Acuna‐Hidalgo et al, 2015; Campbell, Yuan, et al, 2014; Domogala et al, 2021; Shu et al, 2021; Wright et al, 2019). We think this is likely to be an underestimation because low parental allele reads, or analysis pipelines prevent detection of low variant allele copy numbers and the lack of parental phenotypic exams conducted in routine practice.…”
Section: Discussionsupporting
confidence: 75%
“…PM variants could then be passed onto their children and presumed to be a de novo variant (Acuna‐Hidalgo et al, 2015). PM, therefore, may represent an underappreciated source of transmitted variants (Campbell, Yuan, et al, 2014; Shu et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…Somatic mosaicism has been described in a wide variety of genetic disorders with all modes of inheritance and has been observed across different tissues [ 2 16 ]. Recent studies have shown that low-level somatic mosaic variants leading to neurodevelopmental disorders, congenital heart disease, and autism are more prevalent than previously thought [ 17 23 ].…”
Section: Introductionmentioning
confidence: 99%
“…The same variant was found in another unrelated familial case, and despite it could never be confirmed in parents, its presence in both daughters was consistent with germline mosaicism ( Deardorff et al, 2007 ). Although non CdLS-related, an additional case of parental mosaicism in SMC1A was reported in a neurodevelopmental disease, but in this case the mother of the proband was not totally unaffected and suffered from epilepsy ( Shu et al, 2021 ).…”
Section: Discussionmentioning
confidence: 91%